Published
The Committee will discuss new drug application 210934, for sotagliflozin oral tablet, submitted by Lexicon Pharmaceuticals, Inc., for the proposed indication, as an adjunct to insulin therapy, to improve glycemic control in adults with type 1 diabetes mellitus and chronic kidney disease.
- Category
- Management
Be the first to comment
-
9:08:15
March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
-
2:09:03
Infrastructure Task Force Advisory Committee Meeting on October 4, 2021
-
1:10:43
27th Bi-Annual CDC/ATSDR Tribal Advisory Committee Meeting, February 22, 2024. Part 1
-
6:49:31
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
-
6:04:50
Oncologic Drugs Advisory Committee Meeting
-
8:30:00
August 2, 2024 Meeting of the Genetic Metabolic Diseases Advisory Committee (GeMDAC)
-
7:33:16
May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting
-
8:12:21
Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)
-
7:02:20
Census National Advisory Committee - 2024 Spring Meeting: May 2, 2024
-
8:34:46
March 5, 2024 Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC)
-
03:29
Deca Roleplay Video - Lily Papadakis (Marshall) (Business Management)
-
00:20
motivational video for libasna ll inspiration for upsc aspirants ll #short #upse #amitabhbachchan
-
17:46
FreeStyle Libre 3 vs Dexcom G6 | Full Test & Review
-
09:59
Learn Communication Skills | English Speaking | Management Insight #7
-
1:43:58
How to Trade In Stocks By: Jesse Livermore. Complete Audiobook.
-
06:52
Three Questions to Ask Yourself To Be a Great Leader
-
07:35
find your unique style | Style Roots QUIZ + body types
